AlphaCore Capital
RMD icon

AlphaCore Capital’s ResMed RMD Stock Holding History

AlphaCore Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$417K Buy
+1,884
New +$411K 0.01% 917
2026
Q1 		– Sell
-971
Closed -$234K – 1456
2025
Q4 		$234K Buy
+971
New +$248K 0.01% 914
2025
Q3 		– Sell
-423
Closed -$109K – 1122
2025
Q2 		$109K Buy
+423
New +$101K ﹤0.01% 695

Other funds holding RMD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

AlphaCore Capital's RMD Position: Q3 2026 in Review

AlphaCore Capital opened a new position in ResMed (RMD) in Q3 2026: 1,884 shares worth $417K. The stake represents 0.01% of the portfolio and ranks #917 among its holdings. This is a return to the name: AlphaCore Capital previously reported a position in RMD as recently as Q4 2025.

AlphaCore Capital first reported a position in RMD in Q2 2025 and has held it in 3 quarters since. 442 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • AlphaCore Capital held 1,884 shares of ResMed worth $417K as of Q3 2026.
  • ResMed was a new AlphaCore Capital position in Q3 2026.
  • ResMed made up 0.01% of AlphaCore Capital's portfolio in Q3 2026, its #917 holding.
  • AlphaCore Capital first reported a position in ResMed in Q2 2025 and has held it in 3 quarters since.
  • 442 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on AlphaCore Capital's 13F filing for Q3 2026, filed 4 Nov 2026.